Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Russell B McBride"'
Autor:
Mehrvash Haghighi, Dayanandan Adhimoolam, Ricky Kwan, Melissa Gitman, Maria McGuire, Damodara R Mendu, Adolfo Firpo-Betancourt, Russell B McBride, Carlos Cordon-Cardo, Catherine K Craven
Publikováno v:
Journal of Pathology Informatics, Vol 13, Iss 1, Pp 2-2 (2022)
Background: Pandemics are unpredictable and can rapidly spread. Proper planning and preparation for managing the impact of outbreaks is only achievable through continuous and systematic collection and analysis of health-related data. We describe our
Externí odkaz:
https://doaj.org/article/020185d152cc4085b86e5f98cb80b77e
Autor:
Mehrvash Haghighi, Amrita Sethi, Iman Tavassoly, Tamas A Gonda, John M Poneros, Russell B McBride
Publikováno v:
Journal of Pathology Informatics, Vol 10, Iss 1, Pp 34-34 (2019)
Background: Pancreatic cystic lesions are often challenging entities for diagnosis and management. EUS-FNA diagnostic accuracy is limited by paucicellularity of cytology specimens and sampling errors. Needle-based confocal laser endomicroscopy (nCLE)
Externí odkaz:
https://doaj.org/article/d1c322bfc9394d2a81e02a5b53a17999
Autor:
Jonathan T, Dullea, Vikram, Vasan, John W, Rutland, Corey M, Gill, Danielle, Chaluts, Daniel, Ranti, Ethan, Ellis, Varun, Subramanium, Annie, Arrighi-Allisan, Yayoi, Kinoshita, Russell B, McBride, Joshua, Bederson, Michael, Donovan, Robert, Sebra, Melissa, Umphlett, Raj K, Shrivastava
Publikováno v:
Oncoscience. 9:70-81
Meningiomas are common intracranial tumors with variable prognoses not entirely captured by commonly used classification schemes. We sought to determine the relationship between meningioma mutations and oncologic outcomes using a targeted next-genera
Publikováno v:
Inflammatory Bowel Diseases.
Background Histological response to treatment is an important outcome in patients with ulcerative colitis (UC). The accuracy of biopsy-based measurements of inflammation may be limited by error imposed by natural microscopic heterogeneity on the scal
Autor:
Vikram Vasan, Jonathan T. Dullea, Alex Devarajan, Muhammad Ali, John W. Rutland, Corey M. Gill, Yayoi Kinoshita, Russell B. McBride, Paul Gliedman, Joshua Bederson, Michael Donovan, Robert Sebra, Melissa Umphlett, Raj K. Shrivastava
Publikováno v:
Journal of neuro-oncology.
High grade meningiomas have a prognosis characterized by elevated recurrence rates and radiation resistance. Recent work has highlighted the importance of genomics in meningioma prognostication. This study aimed to assess the relationship between the
Autor:
Danielle Chaluts, Jonathan T. Dullea, Muhammad Ali, Vikram Vasan, Alex Devarajan, John W. Rutland, Corey M. Gill, Ethan Ellis, Yayoi Kinoshita, Russell B. McBride, Joshua Bederson, Michael Donovan, Robert Sebra, Melissa Umphlett, Raj K. Shrivastava
Publikováno v:
Journal of cancer research and clinical oncology.
The oncologic outcomes for atypical meningiomas can be poor. Generally, patients that have had a prior recurrence have a substantially elevated risk of a future recurrence. Additionally, certain tumor genomic profiles have been shown as markers of po
Autor:
Margaret Pain, Joshua B. Bederson, Melissa Umphlett, Yayoi Kinoshita, Michael J. Donovan, John W. Rutland, Joshua Loewenstern, Mary Fowkes, Raj K. Shrivastava, Hanane Arib, Corey M. Gill, Russell B. McBride, Robert Sebra
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:3431-3440
While SWI/SNF chromatin remodeling complex alterations occur in approximately 20% of cancer, the frequency and potential impact on clinical outcomes in meningiomas remains to be comprehensively elucidated. A large series of 255 meningiomas from a sin
Autor:
John W. Rutland, Mary Fowkes, Yayoi Kinoshita, Margaret Pain, Joshua B. Bederson, Melissa Umphlett, Russell B. McBride, Robert Sebra, Raj K. Shrivastava, Hanane Arib, Corey M. Gill, Michael J. Donovan, Joshua Loewenstern
Publikováno v:
Neuroradiology. 63:73-80
Meningiomas are the most common primary central nervous system tumor. Emerging data supports that higher mutational burden portends worse clinical outcomes in meningiomas. However, there is a lack of imaging biomarkers that are associated with tumor
Autor:
Joshua Loewenstern, Robert Sebra, Margaret Pain, Melissa Umphlett, Mary Fowkes, Joshua B. Bederson, John W. Rutland, Russell B. McBride, Yayoi Kinoshita, Michael J. Donovan, Raj K. Shrivastava, Hanane Arib, Corey M. Gill
Publikováno v:
Cancer Immunology, Immunotherapy. 70:169-176
The tumor microenvironment is an emerging biomarker of underlying genomic heterogeneity and response to immunotherapy-based treatment regimens in solid malignancies. How tumor mutational burden influences the density, distribution, and presence of a
Autor:
Xiaoyu Song, Valerie McGuire, Daniel L. Rubin, Stacey E. Alexeeff, Weiva Sieh, Laurel A. Habel, Russell B. McBride, Luana Acton, Kezhen Fei, Joseph H. Rothstein, Alice S. Whittemore, Jafi A. Lipson, Lori C. Sakoda, Rhea Y. Liang, Ninah Achacoso, Martin J. Yaffe
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Percent density (PD) is a strong risk factor for breast cancer that is potentially modifiable by lifestyle factors. PD is a composite of the dense (DA) and nondense (NDA) areas of a mammogram, representing predominantly fibroglandular or